Profile
CASI VRTX REGN ALNY SGEN ARGX
Company Name CASI Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $19.99M $117.98B $59.32B $43.28B $43.15B $41.24B
Employees 0.23K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Wei-Wu He Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
CASI VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
CASI VRTX REGN ALNY SGEN ARGX
Last Close $1.29 $462.13 $558.87 $401.8 $228.74 $673.8
High 52 $7.55 $516.74 $1201.76 $401.8 $228.74 $674.17
Low 52 $1.19 $396.64 $482.92 $224.58 $228.74 $484.52
Price vs. 52 Week High -82.91 % -10.57 % -53.5 % 0 % 0 % -0.05 %
Price vs. 52 Week Low 8.4 % 16.51 % 15.73 % 78.91 % 0 % 39.07 %
Total Return
CASI VRTX REGN ALNY SGEN ARGX
1 Month Return -0.77 % 0.55 % 2.1 % 21.06 % 0 % 23.98 %
3 Month Return -33.85 % -7.79 % -7.72 % 54.9 % 0 % 3.71 %
6 Month Return -45.34 % -1.75 % -16.19 % 46.35 % 0 % 2.47 %
9 Month Return -78.54 % -1.91 % -33.75 % 46.69 % 0 % 13.13 %
YTD Return -54.42 % 14.76 % -21.54 % 70.75 % 0 % 9.56 %
1 Year Return -80.72 % -6.54 % -48.36 % 47.69 % 0 % 34.85 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CASI VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 4.37 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
CASI VRTX REGN ALNY SGEN ARGX
Asset Growth -28.69 % -0.87 % 14.15 % 10.71 % -1.21 % 36.55 %
Gross Profit Growth -44.41 % 10.25 % 8.23 % 26.81 % 22.93 % 77.08 %
Revenue Growth -15.77 % 11.66 % 8.27 % 22.97 % 24.65 % 78.6 %
Revenue 3 Year -16.07 % 45.6 % -13.44 % 147.1 % 91.56 % 275.84 %
Revenue 5 Year 332.08 % 163.93 % 82.78 % 775.72 % 215.48 % 1701.04 %
Revenue 10 Year 22320.04 % 1632.15 % 429.43 % 2487.4 % 494.04 % 5950.81 %
EBIT Growth -47.14 % -93.69 % 13.17 % 24.59 % - 128.87 %
Net Income Growth -45.73 % -114.8 % 11.61 % 36.82 % 9.51 % 382.34 %
Net Income 3 Yeari Growth Per Share 7.78 % -122.89 % -46.47 % 69.73 % -763.59 % 274.39 %
Net Income 5 Yeari Growth Per Share 52.24 % -145.38 % 111.07 % 73.13 % -276.93 % 396.61 %
Net Income 10 Yeari Growth Per Share 72.07 % 33.84 % 1232.49 % 55.09 % -624.16 % 938.02 %
Operating Income Growth -57.98 % -106.08 % -1.39 % 37.31 % 10.13 % 94.91 %
Operating Cash Flow Growth (CFG) -46.36 % -113.93 % -3.78 % -107.98 % 9.07 % 80.31 %
Operating 3 Year CFG 3.4 % -118.65 % -38.85 % 98.8 % -147.99 % 88.36 %
Operating 5 Year CFG 21.36 % -131.3 % 84.11 % 97.44 % -195.86 % -135.21 %
Operating 10 Year CFG -36.35 % 12.43 % 517.51 % 97.08 % -2622.09 % -64 %
EPS Growth -26.73 % -114.8 % 10.39 % 38.64 % 10.81 % 369.77 %
EPS Diluted Growth -26.73 % -114.97 % 10.27 % 38.64 % 10.81 % 347.67 %
Book Value Per Share -93.33 % -6.59 % 11.76 % 129.75 % -9.83 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -98.06 % 62.6 % 53.21 % -89.42 % 33.72 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -98.41 % 168.85 % 167.88 % -96.01 % 220.81 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 181.72 % 1265.7 % 1113.59 % -95.83 % 691.19 % 1039.11 %
Dividend Per Share Growth - - - - - -
Dividend 3 Year Growth Per Share - - - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - - - - - -
Debt Growth 4.25 % 116.42 % 0.06 % 2.27 % -23.28 % 95.27 %
Free Cash Flow Growth -32.67 % -124.1 % -0.08 % -201.54 % 3.67 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
CASI VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM 41.31 % 86.03 % 87.44 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -99.16 % -4.32 % 11.67 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -972.55 % -6.25 % 14.43 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -570.43 % -3.89 % 11.12 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 103.03 % 329.41 % 91.46 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 96.9 % 40.44 % 126.92 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -129.26 % -6.69 % 27.02 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 175.35 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM 4.13 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 15.41 3.49 2.47 3.37 1.97 2.39
Inventory Turnover TTM 4.43 1.14 0.56 5.01 0.96 2.93
Fixed Asset Turnover TTM 287.25 % 421.34 % 293.64 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 76.84 % 48.51 % 37.19 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM - -3.82 45.13 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM - -4.9 36.58 -0.58 -2.88 -1.09
Cash Per Share TTM 81.97 % 2413.86 % 7107.14 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 33.37 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM - 128.33 % 81.05 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 175.35 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM - -93.78 15.43 -574.08 -81.26 -533.92
Price To Operating Cash Flows Ratio TTM - -120.39 12.38 -954.11 -93.1 -632.95
Price Cash Flow Ratio TTM - -120.39 12.38 -954.11 -93.1 -632.95
Income Statement (TTM)
CASI VRTX REGN ALNY SGEN ARGX
Revenue $0.03B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.01B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 39.06% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.04B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -2.56 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
CASI VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $2.91B $2.59B $0.04B $0.03B
Total Liabilities $0.05B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.02B $1.75B $2.7B $2.74B $0.04B $0.04B
Total Assets $0.05B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
CASI VRTX REGN ALNY SGEN ARGX
Net Income $-0.04B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0.01B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $-0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 37.2
AARD Aardvark Therapeutics, Inc. Common Stock 12.13
ABCL AbCellera Biologics Inc. 4.24
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.49
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.35
ABPWW 0.0526
ABSI Absci Corporation 2.9
ABUS Arbutus Biopharma Corporation 3.27
ABVC ABVC BioPharma, Inc. 2.75
ABVX Abivax SA American Depositary Shares 71.945
ACAD ACADIA Pharmaceuticals Inc. 23.53
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6706
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.55
ACIU AC Immune SA 2.12
ETFs With Exposure to CASI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 305.74
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 135.8
CHNA Loncar China BioPharma ETF 0.5 13.53
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.18 72.5283
DFAU Dimensional US Core Equity Market ETF 0.000002 42.62
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
Unlock